Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today ...
Structure Therapeutics (GPCR) announced positive topline data from the ACCESS clinical program of aleniglipron for the treatment of people living ...
Structure's aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech's stock up nearly 103% as ...
Investing.com -- Structure Therapeutics Inc ADR (NASDAQ:GPCR) stock soared 28.8% in premarket trading Monday after the company announced positive topline data from its ACCESS clinical program for ...
Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...
Accounting automation allows accounting firms to offer real-time insights to clients by reducing the time spent on manual processes. It creates space for ...
Real-time security clearances are becoming increasingly common in manufacturing of advanced-node semiconductors, where data ...
A recent Bloomberg Intelligence study found that buyside European equity traders want lighter regulation, more retail flow ...
Nigerian entrepreneurs do not build businesses to stay small, but their growth requires systems that defy even the ...
A Fast Shift Toward Smarter Presales In 2025. Presales move fast this year, and many traders now want early-stage crypto ...
Nigerian small businesses must prioritise structure, systems, and data-driven practices to scale sustainably in an economy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback